Stocks

Glaukos GKOS

Health care sectorNYSE

What to see in Glaukos now

Is Wall Street adding or cutting?+30

366 13F filers hold it · +30 against the quarter before · shares held +4.9%

Holdings of 06/30
Are insiders selling?−$249.2K

1 insiders, a net sale of $249.2K in 90 days

Filed 09/28
What comes next?10/13 (Tue)

10/13 estimated earnings

Due 10/13

Company

Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Aliso Viejo, California
Fiscal year end
12/31
Next earnings
10/13, estimated
  • 10/13 estimated earningsDue 10/13
Exchange
NYSE
Headquarters
California
SIC code
Surgical & Medical Instruments & Apparatus
Fiscal year end
12/31
CEO pay (proxy)
$12M · year ended 25/12/31
CEO pay actually paid
$10M · year ended 25/12/31
Next earnings (estimated)
10/13
Last earnings filing
07/29
Korean holdings rank
Outside the top 50

The next earnings day is estimated from the spacing of the last four quarters' 8-K filings.

Korea Securities Depository · released 09/22

Corporate actions

26-week trading

No member of Congress reported a trade in Glaukos GKOS in the past 90 days. Insiders filed 0 purchases and 4 sales on the open market over the same period, a net sale of $249.2K.

Common questions

Did Glaukos GKOS insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 0 purchases and 4 sales on the open market. Sales came to $249.2K.